TY  - JOUR 
AU  - Facultad de Veterinaria
AU  - Rodríguez Gil, Alfonso
AU  - Escamilla Gómez, Virginia
AU  - Nufer, Melanie
AU  - Andújar Sánchez, Félix
AU  - Lopes Ramos, Teresa
AU  - Bejarano García, José Antonio
AU  - García Guerrero, Estefanía
AU  - Calderón Cabrera, Cristina
AU  - Caballero Velázquez, Teresa
AU  - García Calderón, Clara Beatriz
AU  - Hernández Díaz, Paola
AU  - Reguera Ortega, Juan Luis
AU  - Rodríguez Torres, Nancy
AU  - Martínez Cibrián, Nuria
AU  - Rodríguez Barbosa, José Ignacio
AU  - Villadiego, Javier
AU  - Pérez-Simón, José-Antonio
AU  - Sanidad Animal
DA  - 2022
UR  - https://hdl.handle.net/10612/18626
AB  - [EN] Donor derived regulatory T lymphocytes and the JAK1/2 kinase inhibitor ruxolitinib are currently being evaluated as therapeutic options in the treatment of chronic graft versus host disease (cGvHD). In this work, we aimed to determine if the...
LA  - eng
PB  - Nature Research
KW  - Sanidad animal
KW  - T lymphocytes
KW  - Ruxolitinib
KW  - Host disease
KW  - Leukemia
TI  - Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib
DO  - 10.1038/S41598-022-12407-X
T2  - Scientific Reports
VL  - 12
M2  - 8348
ER  -